Terbinafine Hydrochloride Drug Market Report

Terbinafine Hydrochloride Drug Market - Global Professional Analysis and Forecast to 2026

  • POSTDATE：Apr 01, 2020
  • PAGES：175
  • REPORT CODE：GMM528798
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • The worldwide Terbinafine Hydrochloride Drug market was valued at XX.0 Million US$ in 2018 and is projected to reach XX.0 Million US$ by 2026, at a CAGR (Compound Annual Growth Rate) of 4.0% during the forecast period.

    This report presents the market size and development trends by detailing the Terbinafine Hydrochloride Drug market revenue, market share and growth rate from 2015-2026, and it gives a thorough analysis by various product types, applications, regions, and main participants. The market conditions (2015-2019), corporate competition pattern, corporate SWOT analysis are elaborated, and other qualitative analyses like market dynamics, market penetration, market business environment analyses, the regional regulatory scenario in the Terbinafine Hydrochloride Drug market will be shown in this report. In short, this report will comprehensively reveal the characteristics of Terbinafine Hydrochloride Drug industry and will help you to build a panoramic view of the industrial development.

    Terbinafine Hydrochloride Drug Market, By Type:

    • Topical

    • Oral

    Terbinafine Hydrochloride Drug Market, By Application:

    • Athlete's Foot

    • Jock Itch

    • Ringworm

    • Others

    Some of the leading players are as follows:

    • GSK

    • Glenmark

    • Dr Reddy's Laboratories

    • Xiuzheng Pharmaceutical

    • Hubei Hengan Fulin Pharm

    • Breckenridge Pharmaceutical

    • InvaGen Pharmaceuticals

    • Orchid Healthcare

    • Jilin Wantong Group

    • APOTEX

    • CIPLA LTD

    • Dr. Reddy's Laboratories

    • TEVA

    • Harris Pharmaceutical

    • TARO

    • Novartis

    Geographically, Major regions are analyzed in details are as follows:

    • North America

    • Europe

    • Asia Pacific

    • Latin America

    • Middle East & Africa

  • Table of Contents

    1 Methodology and Scope

    • 1.1 Market Segmentation & Scope

      • 1.1.1 Technology Type

      • 1.1.2 Product

      • 1.1.3 Application

      • 1.1.4 Regional scope

      • 1.1.5 Estimates and forecast timeline

    • 1.2 Research Methodology

    • 1.3 Information Procurement

      • 1.3.1 Purchased database

      • 1.3.2 Internal database

      • 1.3.3 Secondary sources

      • 1.3.4 Primary research

      • 1.3.5 Details of primary research

    • 1.4 Information or Data Analysis

      • 1.4.1 Data analysis models

    • 1.5 Market Formulation & Validation

    • 1.6 Model Details

      • 1.6.1 Commodity flow analysis

      • 1.6.2 Volume price analysis

    • 1.7 List of Secondary Sources

    • 1.8 List of Abbreviations

    2 Executive Summary

    • 2.1 Market Outlook

    • 2.2 Segment Outlook

    3 Market Variables, Trends, & Scope

    • 3.1 Market Lineage Outlook

    • 3.1.1 Parent market outlook

      • 3.1.2 Ancillary market outlook

    • 3.2 Market Segmentation

      • 3.2.1 Analysis

    • 3.3 Market Dynamics

      • 3.3.1 Market driver analysis

      • 3.3.2 Market restraint analysis

      • 3.3.3 Industry opportunities

    • 3.4 Penetration & Growth Prospect Mapping

      • 3.4.1 Penetration & growth prospect mapping analysis

    • 3.5 Business Environment Analysis Tools

      • 3.5.1 Porter's five forces analysis

      • 3.5.2 PESTLE analysis

      • 3.5.3 Major deals & strategic alliances analysis

    4 Terbinafine Hydrochloride Drug Market: Technology Type Analysis

    • 4.1 Terbinafine Hydrochloride Drug Technology Type Market Share Analysis, 2018 & 2026

    • 4.2 Terbinafine Hydrochloride Drug Technology Type Market: Segment Dashboard

    • 4.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Technology Type Segment

      • 4.3.1 Topical

      • 4.3.2 Oral

    5 Terbinafine Hydrochloride Drug Market: Product Analysis

    • 5.1 Terbinafine Hydrochloride Drug Product Market Share Analysis, 2018 & 2026

    • 5.2 Terbinafine Hydrochloride Drug Product Market: Segment Dashboard

    • 5.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Product Segment

    6 Terbinafine Hydrochloride Drug Market: Application Analysis

    • 6.1 Terbinafine Hydrochloride Drug Application Market Share Analysis, 2018 & 2026

    • 6.2 Terbinafine Hydrochloride Drug Application Market: Segment Dashboard

    • 6.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Application Segment

      • 6.3.1 Athlete's Foot

      • 6.3.2 Jock Itch

      • 6.3.3 Ringworm

      • 6.3.4 Others

    7 Terbinafine Hydrochloride Drug Market: Regional Analysis

    • 7.1 Terbinafine Hydrochloride Drug Regional Market Share Analysis, 2018 & 2026

    • 7.2 Terbinafine Hydrochloride Drug Regional Market: Segment Dashboard

    • 7.3 Regional Market Snapshot (Market Size, CAGR, Top Countries)

    • 7.4 List of Players at Regional Level

      • 7.4.1 North America

      • 7.4.2 Europe

      • 7.4.3 Asia Pacific

    • 7.5 SWOT Analysis, by Factor (Political & Legal, Economic and Technological)

      • 7.5.1 North America

      • 7.5.2 Europe

      • 7.5.3 Asia Pacific

      • 7.5.4 Latin America

      • 7.5.5 MEA

    • 7.6 Market Size & Forecasts, and Trend Analysis, 2015 to 2026

      • 7.6.1 North America

      • 7.6.2 Europe

      • 7.6.3 Asia Pacific

      • 7.6.4 Latin America

      • 7.6.5 Middle East & Africa

    8 Competitive Analysis

    • 8.1 Recent Developments & Impact Analysis, by Key Market Participants

    • 8.2 Strategic Framework/Competition Categorization (Key innovators, Market leaders, Emerging players)

    • 8.3 Vendor Landscape

      • 8.3.1 Company market position analysis (Geographic presence, service portfolio, strategic initiatives)

    9 Company Profiles

    • 9.1 GSK

      • 9.1.1 GSK Company overview

      • 9.1.2 Financial performance

      • 9.1.3 Product benchmarking

      • 9.1.4 Strategic initiatives

      • 9.1.5 SWOT analysis

    • 9.2 Glenmark

      • 9.2.1 Glenmark Company overview

      • 9.2.2 Financial performance

      • 9.2.3 Product benchmarking

      • 9.2.4 Strategic initiatives

      • 9.2.5 SWOT analysis

    • 9.3 Dr Reddy's Laboratories

      • 9.3.1 Dr Reddy's Laboratories Company overview

      • 9.3.2 Financial performance

      • 9.3.3 Product benchmarking

      • 9.3.4 Strategic initiatives

      • 9.3.5 SWOT analysis

    • 9.4 Xiuzheng Pharmaceutical

      • 9.4.1 Xiuzheng Pharmaceutical Company overview

      • 9.4.2 Financial performance

      • 9.4.3 Product benchmarking

      • 9.4.4 Strategic initiatives

      • 9.4.5 SWOT analysis

    • 9.5 Hubei Hengan Fulin Pharm

      • 9.5.1 Hubei Hengan Fulin Pharm Company overview

      • 9.5.2 Financial performance

      • 9.5.3 Product benchmarking

      • 9.5.4 Strategic initiatives

      • 9.5.5 SWOT analysis

    • 9.6 Breckenridge Pharmaceutical

      • 9.6.1 Breckenridge Pharmaceutical Company overview

      • 9.6.2 Financial performance

      • 9.6.3 Product benchmarking

      • 9.6.4 Strategic initiatives

      • 9.6.5 SWOT analysis

    • 9.7 InvaGen Pharmaceuticals

      • 9.7.1 InvaGen Pharmaceuticals Company overview

      • 9.7.2 Financial performance

      • 9.7.3 Product benchmarking

      • 9.7.4 Strategic initiatives

      • 9.7.5 SWOT analysis

    • 9.8 Orchid Healthcare

      • 9.8.1 Orchid Healthcare Company overview

      • 9.8.2 Financial performance

      • 9.8.3 Product benchmarking

      • 9.8.4 Strategic initiatives

      • 9.8.5 SWOT analysis

    • 9.9 Jilin Wantong Group

      • 9.9.1 Jilin Wantong Group Company overview

      • 9.9.2 Financial performance

      • 9.9.3 Product benchmarking

      • 9.9.4 Strategic initiatives

      • 9.9.5 SWOT analysis

    • 9.10 APOTEX

      • 9.10.1 APOTEX Company overview

      • 9.10.2 Financial performance

      • 9.10.3 Product benchmarking

      • 9.10.4 Strategic initiatives

      • 9.10.5 SWOT analysis

    • 9.11 CIPLA LTD

      • 9.11.1 CIPLA LTD Company overview

      • 9.11.2 Financial performance

      • 9.11.3 Product benchmarking

      • 9.11.4 Strategic initiatives

      • 9.11.5 SWOT analysis

    • 9.12 Dr. Reddy's Laboratories

      • 9.12.1 Dr. Reddy's Laboratories Company overview

      • 9.12.2 Financial performance

      • 9.12.3 Product benchmarking

      • 9.12.4 Strategic initiatives

      • 9.12.5 SWOT analysis

    • 9.13 TEVA

      • 9.13.1 TEVA Company overview

      • 9.13.2 Financial performance

      • 9.13.3 Product benchmarking

      • 9.13.4 Strategic initiatives

      • 9.13.5 SWOT analysis

    • 9.14 Harris Pharmaceutical

      • 9.14.1 Harris Pharmaceutical Company overview

      • 9.14.2 Financial performance

      • 9.14.3 Product benchmarking

      • 9.14.4 Strategic initiatives

      • 9.14.5 SWOT analysis

    • 9.15 TARO

      • 9.15.1 TARO Company overview

      • 9.15.2 Financial performance

      • 9.15.3 Product benchmarking

      • 9.15.4 Strategic initiatives

      • 9.15.5 SWOT analysis

    • 9.16 Novartis

      • 9.16.1 Novartis Company overview

      • 9.16.2 Financial performance

      • 9.16.3 Product benchmarking

      • 9.16.4 Strategic initiatives

      • 9.16.5 SWOT analysis

     

    The List of Tables and Figures (Totals 61 Figures and 144 Tables)

    • Figure Topical Terbinafine Hydrochloride Drug market, 2015 - 2026 (USD Million)

    • Figure Oral Terbinafine Hydrochloride Drug market, 2015 - 2026 (USD Million)

    • Figure Athlete's Foot market, 2015 - 2026 (USD Million)

    • Figure Jock Itch market, 2015 - 2026 (USD Million)

    • Figure Ringworm market, 2015 - 2026 (USD Million)

    • Figure Others market, 2015 - 2026 (USD Million)

    • Table List of players in North America

    • Table List of players in Europe

    • Table List of players in Asia Pacific

    • Table SWOT analysis

    • Table North America Terbinafine Hydrochloride Drug market, by country, 2015 - 2026 (USD Million)

    • Table North America Terbinafine Hydrochloride Drug market, by type, 2015 - 2026 (USD Million)

    • Table North America Terbinafine Hydrochloride Drug market, by product, 2015 - 2026 (USD Million)

    • Table North America Terbinafine Hydrochloride Drug market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table U.S. Terbinafine Hydrochloride Drug market, by type, 2015 - 2026 (USD Million)

    • Table U.S. Terbinafine Hydrochloride Drug market, by product, 2015 - 2026 (USD Million)

    • Table U.S. Terbinafine Hydrochloride Drug market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table Canada Terbinafine Hydrochloride Drug market, by type, 2015 - 2026 (USD Million)

    • Table Canada Terbinafine Hydrochloride Drug market, by product, 2015 - 2026 (USD Million)

    • Table Canada Terbinafine Hydrochloride Drug market, by application, 2015 - 2026 (USD Million)

    • Table Europe Terbinafine Hydrochloride Drug market, by country, 2015 - 2026 (USD Million)

    • Table Europe Terbinafine Hydrochloride Drug market, by type, 2015 - 2026 (USD Million)

    • Table Europe Terbinafine Hydrochloride Drug market, by product, 2015 - 2026 (USD Million)

    • Table Europe Terbinafine Hydrochloride Drug market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table U.K. Terbinafine Hydrochloride Drug market, by type, 2015 - 2026 (USD Million)

    • Table U.K. Terbinafine Hydrochloride Drug market, by product, 2015 - 2026 (USD Million)

    • Table U.K. Terbinafine Hydrochloride Drug market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table Germany Terbinafine Hydrochloride Drug market, by type, 2015 - 2026 (USD Million)

    • Table Germany Terbinafine Hydrochloride Drug market, by product, 2015 - 2026 (USD Million)

    • Table Germany Terbinafine Hydrochloride Drug market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table France Terbinafine Hydrochloride Drug market, by type, 2015 - 2026 (USD Million)

    • Table France Terbinafine Hydrochloride Drug market, by product, 2015 - 2026 (USD Million)

    • Table France Terbinafine Hydrochloride Drug market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table Italy Terbinafine Hydrochloride Drug market, by type, 2015 - 2026 (USD Million)

    • Table Italy Terbinafine Hydrochloride Drug market, by product, 2015 - 2026 (USD Million)

    • Table Italy Terbinafine Hydrochloride Drug market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table Spain Terbinafine Hydrochloride Drug market, by type, 2015 - 2026 (USD Million)

    • Table Spain Terbinafine Hydrochloride Drug market, by product, 2015 - 2026 (USD Million)

    • Table Spain Terbinafine Hydrochloride Drug market, by application, 2015 - 2026 (USD Million)

    • Table Asia Pacific Terbinafine Hydrochloride Drug market, by country, 2015 - 2026 (USD Million)

    • Table Asia Pacific Terbinafine Hydrochloride Drug market, by type, 2015 - 2026 (USD Million)

    • Table Asia Pacific Terbinafine Hydrochloride Drug market, by product, 2015 - 2026 (USD Million)

    • Table Asia Pacific Terbinafine Hydrochloride Drug market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table China Terbinafine Hydrochloride Drug market, by type, 2015 - 2026 (USD Million)

    • Table China Terbinafine Hydrochloride Drug market, by product, 2015 - 2026 (USD Million)

    • Table China Terbinafine Hydrochloride Drug market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table Japan Terbinafine Hydrochloride Drug market, by type, 2015 - 2026 (USD Million)

    • Table Japan Terbinafine Hydrochloride Drug market, by product, 2015 - 2026 (USD Million)

    • Table Japan Terbinafine Hydrochloride Drug market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table India Terbinafine Hydrochloride Drug market, by type, 2015 - 2026 (USD Million)

    • Table India Terbinafine Hydrochloride Drug market, by product, 2015 - 2026 (USD Million)

    • Table India Terbinafine Hydrochloride Drug market, by application, 2015 - 2026 (USD Million)

    • Table Latin America Terbinafine Hydrochloride Drug market, by country, 2015 - 2026 (USD Million)

    • Table Latin America Terbinafine Hydrochloride Drug market, by type, 2015 - 2026 (USD Million)

    • Table Latin America Terbinafine Hydrochloride Drug market, by product, 2015 - 2026 (USD Million)

    • Table Latin America Terbinafine Hydrochloride Drug market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table Brazil Terbinafine Hydrochloride Drug market, by type, 2015 - 2026 (USD Million)

    • Table Brazil Terbinafine Hydrochloride Drug market, by product, 2015 - 2026 (USD Million)

    • Table Brazil Terbinafine Hydrochloride Drug market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table Mexico Terbinafine Hydrochloride Drug market, by type, 2015 - 2026 (USD Million)

    • Table Mexico Terbinafine Hydrochloride Drug market, by product, 2015 - 2026 (USD Million)

    • Table Mexico Terbinafine Hydrochloride Drug market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table Argentina Terbinafine Hydrochloride Drug market, by type, 2015 - 2026 (USD Million)

    • Table Argentina Terbinafine Hydrochloride Drug market, by product, 2015 - 2026 (USD Million)

    • Table Argentina Terbinafine Hydrochloride Drug market, by application, 2015 - 2026 (USD Million)

    • Table MEA Terbinafine Hydrochloride Drug market, by country, 2015 - 2026 (USD Million)

    • Table MEA Terbinafine Hydrochloride Drug market, by type, 2015 - 2026 (USD Million)

    • Table MEA Terbinafine Hydrochloride Drug market, by product, 2015 - 2026 (USD Million)

    • Table MEA Terbinafine Hydrochloride Drug market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table South Africa Terbinafine Hydrochloride Drug market, by type, 2015 - 2026 (USD Million)

    • Table South Africa Terbinafine Hydrochloride Drug market, by product, 2015 - 2026 (USD Million)

    • Table South Africa Terbinafine Hydrochloride Drug market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table Nigeria Terbinafine Hydrochloride Drug market, by type, 2015 - 2026 (USD Million)

    • Table Nigeria Terbinafine Hydrochloride Drug market, by product, 2015 - 2026 (USD Million)

    • Table Nigeria Terbinafine Hydrochloride Drug market, by application, 2015 - 2026 (USD Million)

    • Table Recent Developments & Impact Analysis, by Key Market Participants

    • Table Recent Developments & Impact Analysis, by Key Market Participants

    • Table Company market position analysis

    • Table Company Profiles

    • Table GSK Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table Glenmark Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table Dr Reddy's Laboratories Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table Xiuzheng Pharmaceutical Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table Hubei Hengan Fulin Pharm Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table Breckenridge Pharmaceutical Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table InvaGen Pharmaceuticals Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table Orchid Healthcare Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table Jilin Wantong Group Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table APOTEX Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table CIPLA LTD Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table Dr. Reddy's Laboratories Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table TEVA Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table Harris Pharmaceutical Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table TARO Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table Novartis Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US